1.Clinical application of an intelligent puncture navigation system for percutaneous lung needle biopsy under CT guidance
Weiping XUE ; Kang LIU ; Yaqiong MA ; Yonghao DU ; Yuan WANG ; Gang NIU ; Chenguang GUO ; Ting LIANG
Journal of Practical Radiology 2025;41(7):1207-1210
Objective To explore the impact of an intelligent puncture navigation used by different physicians with varying years of experience to perform the lung puncture biopsy surgery.Methods A retrospective selection was conducted of 182 patients who completed lung puncture biopsy surgery.The primary parameters were recorded included puncture time,the number of needle adjust-ments,dose length product(DLP),and complications.The physicians were categorized into high-experience and low-experience groups based on their years of clinical practice.The differences of navigation guidance and manual puncture were compared between the two groups.Results The use of navigation guidance significantly reduced the procedure time for both groups of physicians(P<0.05).Additionally,for the low-experience group,navigation guidance notably decreased the number of needle adjustments(P<0.05)and reduced the radiation dose received by patients(P<0.05).Conclusion The application of intelligent puncture navigation can shorten the procedure time,reduce the number of needle adjustments,and lower the radiation dose received by patients in lung puncture biopsy procedures.It also bridges the operational performance gap between low-experience and high-experience physicians,making it a val-uable imaging-guided tool for widespread adoption.
2.Buqi-Tongluo Decoction inhibits osteoclastogenesis and alleviates bone loss in ovariectomized rats by attenuating NFATc1, MAPK, NF-κB signaling.
Yongxian LI ; Jinbo YUAN ; Wei DENG ; Haishan LI ; Yuewei LIN ; Jiamin YANG ; Kai CHEN ; Heng QIU ; Ziyi WANG ; Vincent KUEK ; Dongping WANG ; Zhen ZHANG ; Bin MAI ; Yang SHAO ; Pan KANG ; Qiuli QIN ; Jinglan LI ; Huizhi GUO ; Yanhuai MA ; Danqing GUO ; Guoye MO ; Yijing FANG ; Renxiang TAN ; Chenguang ZHAN ; Teng LIU ; Guoning GU ; Kai YUAN ; Yongchao TANG ; De LIANG ; Liangliang XU ; Jiake XU ; Shuncong ZHANG
Chinese Journal of Natural Medicines (English Ed.) 2025;23(1):90-101
Osteoporosis is a prevalent skeletal condition characterized by reduced bone mass and strength, leading to increased fragility. Buqi-Tongluo (BQTL) decoction, a traditional Chinese medicine (TCM) prescription, has yet to be fully evaluated for its potential in treating bone diseases such as osteoporosis. To investigate the mechanism by which BQTL decoction inhibits osteoclast differentiation in vitro and validate these findings through in vivo experiments. We employed MTS assays to assess the potential proliferative or toxic effects of BQTL on bone marrow macrophages (BMMs) at various concentrations. TRAcP experiments were conducted to examine BQTL's impact on osteoclast differentiation. RT-PCR and Western blot analyses were utilized to evaluate the relative expression levels of osteoclast-specific genes and proteins under BQTL stimulation. Finally, in vivo experiments were performed using an osteoporosis model to further validate the in vitro findings. This study revealed that BQTL suppressed receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis and osteoclast resorption activity in vitro in a dose-dependent manner without observable cytotoxicity. The inhibitory effects of BQTL on osteoclast formation and function were attributed to the downregulation of NFATc1 and c-fos activity, primarily through attenuation of the MAPK, NF-κB, and Calcineurin signaling pathways. BQTL's inhibitory capacity was further examined in vivo using an ovariectomized (OVX) rat model, demonstrating a strong protective effect against bone loss. BQTL may serve as an effective therapeutic TCM for the treatment of postmenopausal osteoporosis and the alleviation of bone loss induced by estrogen deficiency and related conditions.
Animals
;
NFATC Transcription Factors/genetics*
;
Drugs, Chinese Herbal/pharmacology*
;
Ovariectomy
;
Osteoclasts/metabolism*
;
Female
;
Osteogenesis/drug effects*
;
Rats, Sprague-Dawley
;
Rats
;
NF-kappa B/genetics*
;
Osteoporosis/genetics*
;
Signal Transduction/drug effects*
;
Bone Resorption/genetics*
;
Cell Differentiation/drug effects*
;
Humans
;
RANK Ligand/metabolism*
;
Mitogen-Activated Protein Kinases/genetics*
;
Transcription Factors
3.Clinical application of an intelligent puncture navigation system for percutaneous lung needle biopsy under CT guidance
Weiping XUE ; Kang LIU ; Yaqiong MA ; Yonghao DU ; Yuan WANG ; Gang NIU ; Chenguang GUO ; Ting LIANG
Journal of Practical Radiology 2025;41(7):1207-1210
Objective To explore the impact of an intelligent puncture navigation used by different physicians with varying years of experience to perform the lung puncture biopsy surgery.Methods A retrospective selection was conducted of 182 patients who completed lung puncture biopsy surgery.The primary parameters were recorded included puncture time,the number of needle adjust-ments,dose length product(DLP),and complications.The physicians were categorized into high-experience and low-experience groups based on their years of clinical practice.The differences of navigation guidance and manual puncture were compared between the two groups.Results The use of navigation guidance significantly reduced the procedure time for both groups of physicians(P<0.05).Additionally,for the low-experience group,navigation guidance notably decreased the number of needle adjustments(P<0.05)and reduced the radiation dose received by patients(P<0.05).Conclusion The application of intelligent puncture navigation can shorten the procedure time,reduce the number of needle adjustments,and lower the radiation dose received by patients in lung puncture biopsy procedures.It also bridges the operational performance gap between low-experience and high-experience physicians,making it a val-uable imaging-guided tool for widespread adoption.
4.Advances in surgical strategies for ossification of posterior longitudinal ligament involving the C 2 segment.
Teng LIU ; Guoning GU ; Chenguang ZHAN ; Haishan LI ; Huizhi GUO ; Yongxian LI ; Guoye MO ; Kai YUAN ; Shuncong ZHANG ; Zhidong YANG ; Yongchao TANG
Chinese Journal of Reparative and Reconstructive Surgery 2023;37(6):742-747
OBJECTIVE:
To evaluate the application of surgical strategies for the treatment of cervical ossification of the posterior longitudinal ligament (OPLL) involving the C 2 segment.
METHODS:
The literature about the surgery for cervical OPLL involving C 2 segment was reviewed, and the indications, advantages, and disadvantages of surgery were summarized.
RESULTS:
For cervical OPLL involving the C 2 segments, laminectomy is suitable for patients with OPLL involving multiple segments, often combined with screw fixation, and has the advantages of adequate decompression and restoration of cervical curvature, with the disadvantages of loss of cervical fixed segmental mobility. Canal-expansive laminoplasty is suitable for patients with positive K-line and has the advantages of simple operation and preservation of cervical segmental mobility, and the disadvantages include progression of ossification, axial symptoms, and fracture of the portal axis. Dome-like laminoplasty is suitable for patients without kyphosis/cervical instability and with negative R-line, and can reduce the occurrence of axial symptoms, with the disadvantage of limited decompression. The Shelter technique is suitable for patients with single/double segments and canal encroachment >50% and allows for direct decompression, but is technically demanding and involves risk of dural tear and nerve injury. Double-dome laminoplasty is suitable for patients without kyphosis/cervical instability. Its advantages are the reduction of damage to the cervical semispinal muscles and attachment points and maintenance of cervical curvature, but there is progress in postoperative ossification.
CONCLUSION
OPLL involving the C 2 segment is a complex subtype of cervical OPLL, which is mainly treated through posterior surgery. However, the degree of spinal cord floatation is limited, and with the progress of ossification, the long-term effectiveness is poor. More research is needed to address the etiology of OPLL and to establish a systematic treatment strategy for cervical OPLL involving the C 2 segment.
Humans
;
Longitudinal Ligaments/surgery*
;
Ossification of Posterior Longitudinal Ligament/surgery*
;
Treatment Outcome
;
Osteogenesis
;
Decompression, Surgical/methods*
;
Cervical Vertebrae/surgery*
;
Laminoplasty/methods*
;
Kyphosis/surgery*
;
Retrospective Studies
5.Risk factors for deep vein thrombosis after a spinal cord injury: A retrospective study
Miaoqiao SUN ; Mulan XU ; Xiangbo WU ; Ying LIANG ; Xiao XI ; Yixing LU ; Guiqing CHENG ; Hong WANG ; Ning LI ; Chenguang ZHAO ; Xiaolong SUN ; Hua YUAN
Chinese Journal of Physical Medicine and Rehabilitation 2023;45(4):302-306
Objective:To explore the risk factors for lower extremity deep vein thrombosis (DVT) in patients with a spinal cord injury (SCI).Methods:The medical records of 276 hospitalized SCI patients were analyzed retrospectively. They were divided into a DVT group ( n=63) and a no-DVT group ( n=213). Gender, age, blood type, smoking history, surgical history, the time from SCI to admission, cause of SCI, fracture, SCI segments, American Spinal Cord Injury Association grade and complications were compared between the two groups. Binomial logistic regression was used to isolate the risk factors for lower extremity DVT among such patients. Results:Among 84% of the 63 with a lower extremity DVT, it was a calf muscle venous thrombosis. Anemia, hyponatremia and time from SCI to admission (which ranged from 74 to 195 days) were the most serious DVT risk factors.Conclusions:SCI patients are of high risk for DVT, with anemia and hyponatremia being independent risk factors.
6.Study on the Medical Device Registration Submission Dossier Requirements in China.
Min CHEN ; Chenguang ZHANG ; Yinghui LIU ; Peng YUAN ; Gang DENG
Chinese Journal of Medical Instrumentation 2022;46(4):428-432
The evolution throughout the whole supervision history of Class II/III safety and effectiveness related NMPA submission dossier requirements was studied in this study, meanwhile elaborating the revolution progress of clinical evaluation domestically. The relationship between submission dossier requirements and Essential Principles of Safety and Performance of Medical Devices as well as IMDRF relevant documents was deeply analyzed and illustrated, in order to comprehensively understanding the background and future reform direction of NMPA submission dossier requirements under the background of the government's deepening reform of medical device evaluation and approval system strategy.
China
;
Device Approval
;
Humans
7.Risk factors for neuropathic pain after a spinal cord injury: A retrospective study
Mulan XU ; Xiaolong SUN ; Xiangbo WU ; Miaoqiao SUN ; Hong WANG ; Yani ZHANG ; Mi GAO ; Xu HU ; Hui CAO ; Wei SUN ; Chenguang ZHAO ; Hua YUAN
Chinese Journal of Physical Medicine and Rehabilitation 2022;44(3):199-203
Objective:To examine the risk factors for neuropathic pain (NP) after a spinal cord injury (SCI).Methods:A total of 115 patients with a SCI were analyzed retrospectively. They were divided into an NP group of 53 and a non-NP group of 62 according to the occurrence of NP. Gender, age, length of stay, occupation, level of education, cause of injury, spinal fracture, degree of SCI, the injury′s plane and complications at admission (diabetes, hypertension, anemia, venous thrombosis, pressure sores, urinary tract infection or hypoproteinemia) were recorded. T-tests and chi-squared tests were used to compare those factors between the two groups, and multivariate logistic regressions were evaluated to identify the risk factors for NP.Results:Twenty-three of the 53 cases of NP (43%) had developed within 1 month of the SCI. Thirty-seven (75%) experienced pain below the plane of the SCI. The main features reported were squeezing (34%) and numbness (26%). The multivariate logistic regression showed that the occurrence of NP was most strongly related to gender (women being particularly at risk) and venous thrombosis at admission.Conclusions:Women are at particular risk of feeling NP after an SCI, and venous thrombosis is an independent risk factor. NP should be diagnosed and treated quickly to reduce the negative impact on patients′ life quality.
8.Transcranial magnetic stimulation relieves pain and improves cortical excitability after stroke
Wei SUN ; Chenguang ZHAO ; Hua YUAN ; Xiang MU
Chinese Journal of Physical Medicine and Rehabilitation 2019;41(4):252-256
Objective To investigate the effect of repeatedly applying transcranial magnetic stimulation (rTMS) in treating post-stroke pain (CPSP).Methods Forty stroke survivors experiencing CPSP were randomly divided into a treatment group and a control group,each of 20.All of the patients received conventional rehabilitation.In the treatment group,20 patients received 10 Hz rTMS at 80% of their resting motor threshold applied over the primary motor cortex on their affected side,while those in the control group received sham stimulation.Both groups were treated once a day,6 times a week for 4 weeks.Before and after the treatment,both groups were assessed using a pain score self-assessed on a visual analogue scale (VAS).Their resting motor thresholds (RMTs),cortical silent periods (CSPs) and motor evoked potentials (MEPs) were also recorded.Results After the intervention,the average VAS score,RMT,CSP and M EP latency of the treatment group were (3.1±1.2),(51.3±4.8)%,(188.9± 63.0) ms and (27.9±5.7)ms,all significantly better than those before the intervention [(5.1± 1.3),(60.1±5.9)%,(239.7±43.5) ms and (35.5±4.4)ms] (P<0.05).They were also significantly better than those of the control group after the intervention [(4.7±1.0),(57.6±5.1)%,(241.7±33.9)ms and (31.7±5.2)ms] (P<0.05).Conclusion Transcranial magnetic stimulation can relieve post-stroke pain.The mechanisms might be related to positive changes in cortical excitability in the affected hemisphere.
9. A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM
Wei YUAN ; Chenguang SUI ; Xiao MA ; Jie MA
Chinese Journal of Oncology 2018;40(5):330-334
Objective:
To explore new multidrug resistant genes of pancreatic cancer by establishment and characterization of chemo-resistant cell lines.
Methods:
The cisplatin-resistant cell line JF305/CDDP and the gemcitabine-resistant cell line PANC-1/GEM were induced by high-dose intermittent treatment. CCK-8 assay was used to detect the 50% inhibiting concentration (IC50), drug resistance index (R), cross-resistance, and growth difference of different cells. The changes of cell cycle and migration ability of drug-resistant cells were determined by flow cytometry and transwell assay, respectively. And then real-time fluorescence quantitative PCR was used to detect the expression of multidrug resistance-related genes.
Results:
The drug resistance indexes of JF305/CDDP and PANC-1/GEM were 15.3 and 27.31, respectively, and there was cross-resistance. Compared with the parental cells, the proliferation rate of JF305/CDDP was decreased by 40% on the fourth day (
10.Poorly differentiated endocardial sarcoma: a case report
Chenguang ZHU ; Xuehua HE ; Yonghua YUAN ; Yimin ZHU ; Liping LIU ; Zhenyu LIU ; Qianli ZHU ; Wenwu ZHOU ; Yanchun LI
Journal of Clinical Pediatrics 2017;35(4):290-292
Objective To explore the diagnosis and treatment of poorly differentiated endocardial sarcoma. Method The clinical data of a child with poorly differentiated endocardial sarcoma was retrospectively analyzed. Results One-year-old girl was admitted for diarrhea, polypnea, cyanosis, and cough. Abnormal heart sound was found by auscultation. Leads Ⅱ, Ⅲ, and aVF of ECG showed high peaked P wave. The diagnosis of poorly differentiated endocardial sarcoma was confirmed by echocardiography and pathology after cardiac operation. Three months after discharge from the hospital, the patient suddenly came into coma and died. Conclusion The diagnosis of poorly differentiated endocardial sarcoma is mainly based on clinical manifestations, echocardiography and pathology. Surgical resection is the first choice and chemotherapy and radiotherapy play a supporting role. However, there is no cure for it currently.

Result Analysis
Print
Save
E-mail